ONCOLOGY LYOPHILIZED INJECTABLES

Product Description

AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
Specifications
  • Details
    Venus Remedies Limited/Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, proudly holds EU-GMP certification in injectable manufacturing, EU APPROVED INJECTABLES MANUFACTUER
  • Selling Points
    Brand Name; Convenience; Ethical Sourcing; Experienced Technicians; Guarantee/Warranty; International Approvals/Standards; Packaging; Product Features; Product Performance; Prompt Delivery; Quality Service; Reputation; Sustainability; Venus Remedies Limited/Venus Pharma GmbH, is considered among the top-class manufacturers of oncological, carbapenem and cephalosporin injectable products. The company is contributing substantially in the oncology segment across the globe through its wide array of key products, which include Docetaxel, Paclitaxel, Gemcitabine, Oxaliplatin, Bortezomib and Pemetrexed.
  • Supplied from
    Germany; India

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs

More Products from Venus Pharma GmbH (4)

  • ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    Product ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM F...
  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH resources (2)